DPP9 and neoplasm: Following the lowering of liver tumour burden by pan-DPP inhibition, Huang et al. knocked out DPP9 only in hepatocytes to find a similar, but muted, outcome in the same liver cancer model, with lowered tumour burden only amongst small tumours.